Status epilepticus admissions during the COVID-19 pandemic in Salzburg-A population-based study

Markus Leitinger1,2, Kai-Nicolas Poppert1,2, Matthias Mauritz1,2

  • 1Department of Neurology, Christian Doppler University Hospital, Paracelsus Medical University, Affiliated partner of the ERN EpiCARE, Salzburg, Austria.

Epilepsia
|November 3, 2020
PubMed

Insights

During the COVID-19 pandemic, hospital admissions for first-time status epilepticus (SE) remained stable. However, a trend toward underdiagnosing nonconvulsive SE (NCSE) suggests potential disparities in care.

Area of Science:

  • Neurology
  • Epidemiology

Background:

  • The COVID-19 pandemic led to reduced hospital admissions for many emergencies.
  • It is unknown if this trend affected patients experiencing first-time status epilepticus (SE).

Purpose of the Study:

  • To compare the incidence of first SE admissions during the COVID-19 pandemic (March-April 2020) with pre-pandemic periods (January-February 2020) and previous years (2018-2019).

Main Methods:

  • Retrospective cohort analysis of hospital patient database.
  • Independent review by two investigators to identify all forms of SE.
  • Comparison of incidence rates before and during the early COVID-19 pandemic.

Main Results:

  • No significant change in the incidence of first SE admissions was observed during the COVID-19 pandemic compared to pre-pandemic periods and previous years.
  • Estimated incidence aligned with prior 5-year epidemiological data for Salzburg.
  • A trend toward less frequent nonconvulsive SE (NCSE) and loss of female predominance suggested potential underdiagnosis.

Conclusions:

  • Status epilepticus admissions did not decrease during the early COVID-19 pandemic, likely due to its prominent symptom of impaired consciousness.
  • Further research is needed on the medical support for women and NCSE patients during pandemic restrictions.